Wider statin use recommended for chronic kidney disease

December 10, 2013
Wider statin use recommended for chronic kidney disease

(HealthDay)—New guidelines for lipid management in chronic kidney disease (CKD) recommend wider statin use, according to a clinical practice guideline published online Dec. 10 in the Annals of Internal Medicine.

Marcello Tonelli, M.D., from the University of Alberta in Edmonton, Canada, and colleagues reviewed and graded the evidence and developed a on lipid management and treatment of all adults and children with CKD.

The guidelines include 13 recommendations, with eight recommendations relating to assessment of lipid status and treatment with statin-based regimens. For adults ≥50 years with an estimated (eGFR) <60 mL/min/1.73 m², not treated with chronic dialysis or kidney transplantation, treatment with a statin or statin/ezetimibe combination is recommended. Statin treatment is recommended for adults aged ≥50 years with CKD and eGFR ≥60 mL/min/1.73 m². Younger adults (18 to 49 years) with CKD who are not treated with chronic dialysis or kidney transplantation should receive statin treatment if they have at least one of the following: known coronary disease, diabetes mellitus, prior ischemic stroke, or >10 percent estimated 10-year incidence of coronary death or non-fatal myocardial infarction. Statins or statin/ezetimibe combinations should not be initiated for adults with dialysis-dependent CKD, although treatment can be continued for those receiving it at dialysis initiation. Adult should also be treated with a statin. Adults with newly identified CKD should be evaluated with a lipid profile, but follow-up measurements are not required.

"Within the guideline, implications for clinical practice, future research, and implementation in international settings are highlighted," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Explore further: ACP recommends against screening for chronic kidney disease in adults without symptoms, risk factors

More information: Full Text

Related Stories

ACP recommends against screening for chronic kidney disease in adults without symptoms, risk factors

October 21, 2013
The American College of Physicians (ACP) recommends against screening for chronic kidney disease (CKD) in asymptomatic adults without risk factors. ACP's new clinical practice guideline, "Screening, Monitoring, and Treatment ...

New cholesterol guidelines biggest change in more than 25 years

November 26, 2013
(Medical Xpress)—New cholesterol guidelines for identifying adults at risk for heart disease represent the biggest change in such expert advice in more than 25 years, according to Loyola University Health System preventive ...

ACC/AHA publish new guideline for management of blood cholesterol

November 12, 2013
The American College of Cardiology and the American Heart Association today released a new clinical practice guideline for the treatment of blood cholesterol in people at high risk for cardiovascular diseases caused by atherosclerosis, ...

Early statin therapy helps kids with inherited high cholesterol

November 18, 2013
Children with inherited high levels of cholesterol who receive cholesterol-lowering statins in their early years have a lower risk of coronary heart disease than their affected parents, according to research presented at ...

Prevalence of poorer kidney function increases among adults 80 years of age and older

September 24, 2013
Recent studies have shown that older adults with chronic kidney disease (CKD; defined as an estimated glomerular filtration rate [GFR; a measure of kidney function] of less than 60 mL/min/1.73 m2) have a high prevalence of ...

High potency statins pose significantly higher risk of kidney injury than low potency, say experts

March 19, 2013
Patients taking high potency statins for high blood pressure are at a 34% higher risk of being hospitalised for acute kidney injury (AKI), compared with those taking low potency statins, a paper published today in BMJ suggests.

Recommended for you

H7N9 influenza is both lethal and transmissible in animal model for flu

October 19, 2017
In 2013, an influenza virus that had never before been detected began circulating among poultry in China. It caused several waves of human infection and in late 2016, the number of people to become sick from the H7N9 virus ...

Migraines may be the brain's way of dealing with oxidative stress

October 19, 2017
A new perspective article highlights a compelling theory about migraine attacks: that they are an integrated mechanism by which the brain protects and repairs itself. Recent insightful findings and potential ways to use them ...

Flu simulations suggest pandemics more likely in spring, early summer

October 19, 2017
New statistical simulations suggest that Northern Hemisphere flu pandemics are most likely to emerge in late spring or early summer at the tail end of the normal flu season, according to a new study published in PLOS Computational ...

New insights into herpes virus could inform vaccine development

October 18, 2017
A team of scientists has discovered new insights into the mechanisms of Epstein-Barr virus (EBV) infection, as well as two antibodies that block the virus' entry into cells. The findings, published in Proceedings of the National ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

Portable 3-D scanner assesses patients with elephantiasis

October 17, 2017
An estimated 120 million people worldwide are infected with lymphatic filariasis, a parasitic, mosquito-borne disease that can cause major swelling and deformity of the legs, a condition known as elephantiasis. Health-care ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.